Publication Cover
Expert Review of Precision Medicine and Drug Development
Personalized medicine in drug development and clinical practice
Volume 3, 2018 - Issue 1
4,843
Views
5
CrossRef citations to date
0
Altmetric
Special Report

The economic case for precision medicine

, &
Pages 1-9 | Received 23 Oct 2017, Accepted 22 Dec 2017, Published online: 08 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Marzieh Nosrati, Shekoufeh Nikfar & Mandana Hasanzad. (2022) A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trials. Expert Review of Pharmacoeconomics & Outcomes Research 22:7, pages 1061-1070.
Read now
Marzieh Nosrati & Shekoufeh Nikfar. (2021) Conducting economic evaluation based on basket clinical trial in the area of precision medicine. Expert Review of Pharmacoeconomics & Outcomes Research 21:2, pages 169-171.
Read now
Carlos Carretero-Puche, Santiago García-Martín, Rocío García-Carbonero, Gonzalo Gómez-López & Fátima Al-Shahrour. (2020) How can bioinformatics contribute to the routine application of personalized precision medicine?. Expert Review of Precision Medicine and Drug Development 5:3, pages 115-117.
Read now
Megan Sutcliffe, Gemma Radley & Anne Barton. (2020) Personalized medicine in rheumatic diseases: how close are we to being able to use genetic biomarkers to predict response to TNF inhibitors?. Expert Review of Clinical Immunology 16:4, pages 389-396.
Read now
J.-Matthias Löhr, Maximilian Kordes, Wiktor Rutkowski, Rainer Heuchel, Maria Gustafsson-Liljefors, Aman Russom & Mats Nilsson. (2018) Overcoming diagnostic issues in precision treatment of pancreatic cancer. Expert Review of Precision Medicine and Drug Development 3:3, pages 189-195.
Read now